{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:50:34Z","timestamp":1762606234396},"reference-count":51,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.3892\/ijo.2013.1880","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T09:31:56Z","timestamp":1364981516000},"page":"1883-1889","source":"Crossref","is-referenced-by-count":9,"title":["Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines"],"prefix":"10.3892","volume":"42","author":[{"given":"M. WAHEED","family":"ROOMI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATIANA","family":"KALINOVSKY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALEKSANDRA","family":"NIEDZWIECKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MATTHIAS","family":"RATH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"key20180107181327_b1-ijo-42-06-1883","unstructured":"American Cancer SocietyLung cancer: What are the key statistics about lung cancerhttp:\/\/www.cancer.org\/cancer\/lungcancer-non-small-cell\/detailedguide\/non-smallcell-lung-cancer-key-statistics (Accessed 12\/3\/2012) Last revised: 10\/12\/2012"},{"key":"key20180107181327_b2-ijo-42-06-1883","unstructured":"American Lung AssociationLung Cancer Fact Sheethttp:\/\/www.lung.org\/lung-disease\/lung-cancer\/resources\/facts-figures\/lung-cancer-fact-sheet.html (Accessed 12\/3\/2012) Last revised 2012."},{"key":"key20180107181327_b3-ijo-42-06-1883","unstructured":"American Cancer SocietyMalignant Mesotheliomahttp:\/\/www.cancer.org\/cancer\/malignantmesothelioma\/detailedguide\/malignant-mesothelioma-survival-statistics (Accessed 12\/3\/2012) Last revised 9\/20\/2012."},{"key":"key20180107181327_b4-ijo-42-06-1883","first-page":"135","article-title":"Molecular biology of cancer: invasion and metastasis","volume-title":"Cancer: Principles and Practice of Oncology","author":"Fidler","year":"1997","edition":"5th edition"},{"key":"key20180107181327_b5-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 16","key":"key20180107181327_b6-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"key20180107181327_b7-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views on the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl","key":"key20180107181327_b8-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43","author":"Kleiner","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107181327_b9-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1096\/fasebj.4.6.2180767","article-title":"Molecular architecture of basement membranes","volume":"4","author":"Yurchenko","year":"1990","journal-title":"FASEB J"},{"key":"key20180107181327_b10-ijo-42-06-1883","first-page":"140","article-title":"Loss of basement membrane components by invasive tumors but not by their benign counterparts","volume":"49","author":"Barsky","year":"1983","journal-title":"Lab Investig"},{"key":"key20180107181327_b11-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/284067a0","article-title":"Metastatic potential correlates with enzymatic degradation of basement membrane collagen","volume":"284","author":"Liotta","year":"1980","journal-title":"Nature"},{"key":"key20180107181327_b12-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1200\/JCO.2000.18.5.1135","article-title":"Matrix metalloproteinases: biologic activity and clinical implications","volume":"18","author":"Nelson","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180107181327_b13-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000064034","article-title":"Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung","volume":"23","author":"Sch\u00fcltz","year":"2002","journal-title":"Tumor Biol"},{"key":"key20180107181327_b14-ijo-42-06-1883","first-page":"97","article-title":"Analysis of circulating plasma matrix metalloproteinases (MMP) and tissue inhibitors of MMP in lung cancer patients","volume":"59","author":"Takashi","year":"2000","journal-title":"J Nihon Univ Med Assoc"},{"key":"key20180107181327_b15-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s007950200002","article-title":"Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens and ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study","volume":"35","author":"Hirano","year":"2002","journal-title":"Med Electron Microsc"},{"key":"key20180107181327_b16-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6600920","article-title":"Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura","volume":"88","author":"Edwards","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107181327_b17-ijo-42-06-1883","first-page":"4147","article-title":"Cathepsin B, plasminogen activator-inihbitor (PAI-1) and plasminogen activator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer","volume":"24","author":"Werle","year":"2004","journal-title":"Anticancer Res"},{"key":"key20180107181327_b18-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"L972","DOI":"10.1152\/ajplung.1995.268.6.L972","article-title":"Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis","volume":"268","author":"Shetty","year":"1995","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key20180107181327_b19-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1055-3207(18)30071-1","article-title":"The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis","volume":"10","author":"Stetler-Stevenson","year":"2001","journal-title":"Surg Oncol Clin North Am"},{"key":"key20180107181327_b20-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00049520","article-title":"Type IV collagenases in tumor invasion and metastasis","volume":"9","author":"Stetler-Stevenson","year":"1990","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107181327_b21-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-230X(08)60028-7","article-title":"Plasminogen activators, tissue degradation and cancer","volume":"44","author":"Dano","year":"1985","journal-title":"Adv Cancer Res"},{"key":"key20180107181327_b22-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/clinchem\/44.6.1177","article-title":"Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease","volume":"44","author":"Duffy","year":"1998","journal-title":"Clin Chem"},{"key":"key20180107181327_b23-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.200903-0342OC","article-title":"Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model","volume":"181","author":"Henneke","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180107181327_b24-ijo-42-06-1883","first-page":"1318","article-title":"Regulation of fibrin deposition by malignant mesothelioma","volume":"147","author":"Idell","year":"1995","journal-title":"Am J Pathol"},{"key":"key20180107181327_b25-ijo-42-06-1883","first-page":"17","article-title":"Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs","volume":"7","author":"Rath","year":"1992","journal-title":"Orthomolecular Med"},{"key":"key20180107181327_b26-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z","article-title":"The urokinase-type plasminogen activator system in cancer metastasis: a review","volume":"72","author":"Andreasen","year":"1997","journal-title":"Int J Cancer"},{"key":"key20180107181327_b27-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10555-010-9244-1","article-title":"Micronutrient synergy - a new tool in effective control of metastasis and other key mechanisms of cancer","volume":"29","author":"Niedzwiecki","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107181327_b28-ijo-42-06-1883","first-page":"243","article-title":"Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: a correlation study","volume":"32","author":"Roomi","year":"2010","journal-title":"Exp Oncol"},{"key":"key20180107181327_b29-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/01902140601047658","article-title":"In vivo and in vitro anti-tumor effect of a unique nutrient mixture on lung cancer cell line A-549","volume":"32","author":"Roomi","year":"2006","journal-title":"Exp Lung Res"},{"key":"key20180107181327_b30-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2008.20.6235","article-title":"Perspectives for cancer prevention with natural compounds","volume":"27","author":"Amin","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107181327_b31-ijo-42-06-1883","first-page":"747","article-title":"Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines","volume":"24","author":"Roomi","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107181327_b32-ijo-42-06-1883","first-page":"182","article-title":"The blockage of high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation","volume":"1596","author":"Sun","year":"2002","journal-title":"Biochem Biophys Acta"},{"key":"key20180107181327_b33-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/01.ju.0000081278.64511.96","article-title":"Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate","volume":"170","author":"Kemberling","year":"2003","journal-title":"J Urol"},{"key":"key20180107181327_b34-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1442-2042.2003.00587.x","article-title":"Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves","volume":"10","author":"Sato","year":"2003","journal-title":"Int J Urol"},{"key":"key20180107181327_b35-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00001813-199606000-00011","article-title":"Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines","volume":"7","author":"Valcic","year":"1996","journal-title":"Anticancer Drugs"},{"key":"key20180107181327_b36-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"S1698","DOI":"10.1093\/ajcn\/71.6.1698S","article-title":"Tea polyphenols: prevention of cancer and optimizing health","volume":"71","author":"Mukhtar","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"key20180107181327_b37-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/carcin\/19.4.611","article-title":"Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols","volume":"19","author":"Yang","year":"1998","journal-title":"Carcinogenesis"},{"key":"key20180107181327_b38-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3835(92)90212-E","article-title":"Effect of (-) epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines","volume":"65","author":"Taniguchi","year":"1992","journal-title":"Cancer Lett"},{"key":"key20180107181327_b39-ijo-42-06-1883","doi-asserted-by":"crossref","DOI":"10.1201\/9780203907993","volume-title":"Green tea: Health Benefits and Applications","author":"Hara","year":"2001"},{"key":"key20180107181327_b40-ijo-42-06-1883","first-page":"213","article-title":"Inhibitory effects of N-acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells","volume":"21","author":"Kawakami","year":"2001","journal-title":"Anticancer Res"},{"key":"key20180107181327_b41-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/172460089901400413","article-title":"The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis","volume":"14","author":"Morini","year":"1999","journal-title":"Int J Biol Markers"},{"key":"key20180107181327_b42-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"20085","DOI":"10.1074\/jbc.M101143200","article-title":"Inhibitory effects of selenite on invasion of HT 1080 tumor cells","volume":"276","author":"Yoon","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107181327_b43-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1023\/A:1021779624971","article-title":"Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor","volume":"48","author":"Naidu","year":"2003","journal-title":"Dig Dis Sci"},{"key":"key20180107181327_b44-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1982.211","article-title":"Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance","volume":"46","author":"Anthony","year":"1982","journal-title":"Br J Cancer"},{"key":"key20180107181327_b45-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1097-0045(19970801)32:3<188::AID-PROS5>3.0.CO;2-H","article-title":"Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis","volume":"32","author":"Maramag","year":"1997","journal-title":"Prostate"},{"key":"key20180107181327_b46-ijo-42-06-1883","first-page":"2487","article-title":"Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines","volume":"8","author":"Koh","year":"1998","journal-title":"Anticancer Res"},{"key":"key20180107181327_b47-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181327_b48-ijo-42-06-1883","first-page":"368","article-title":"Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin","volume":"10","author":"Nunez","year":"1995","journal-title":"Nutr Hosp"},{"key":"key20180107181327_b49-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-3835(96)04212-7","article-title":"Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin and paclitaxel in human breast carcinoma cells in vitro","volume":"103","author":"Kurbacher","year":"1996","journal-title":"Cancer Lett"},{"key":"key20180107181327_b50-ijo-42-06-1883","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.med.48.1.489","article-title":"Nitric oxide synthase: role in the genesis of vascular disease","volume":"48","author":"Cooke","year":"1997","journal-title":"Annu Rev Med"},{"key":"key20180107181327_b51-ijo-42-06-1883","first-page":"77","article-title":"Serum markers of the liver, heart and kidney and lipid profile and histopathology in ODS rats treated with nutrient synergy","volume":"22","author":"Roomi","year":"2003","journal-title":"J Am Coll Nutr"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1880\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T19:12:15Z","timestamp":1595617935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,4,3]]},"published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.3892\/ijo.2013.1880"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1880","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}